Variation in Antithrombotic Therapy and Clinical Outcomes in Patients with Preexisting Atrial Fibrillation Undergoing TAVR: Insights from the STS/ACC TVT Registry(®)

BACKGROUND: Optimal antithrombotic management of patients with pre-existing atrial fibrillation (AF) undergoing transcatheter aortic valve replacement (TAVR) is challenging given the need to balance the risk of bleeding and thromboembolism. We aimed to examine variation in care and association of an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Cardiovasc Interv
Autors principals: Sherwood, Matthew W., Gupta, Aakriti, Vemulapalli, Sreekanth, Li, Zhuokai, Piccini, Jonathan, Harrison, J. Kevin, Dai, David, Vora, Amit N., Mack, Michael J., Holmes, David R., Rumsfeld, John S., Cohen, David J., Thourani, Vinod H., Kirtane, Ajay J., Peterson, Eric D.
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300574/
https://ncbi.nlm.nih.gov/pubmed/33877866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCINTERVENTIONS.120.009963
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars